EphA2 Is a Clinically Relevant Target for Breast Cancer Bone Metastatic Disease.

Autor: Vaught DB; Department of Cancer Biology Vanderbilt University School of Medicine Nashville TN USA., Merkel AR; Vanderbilt Center for Bone Biology Vanderbilt University School of Medicine Nashville TN USA., Lynch CC; Department of Tumor Biology H. Lee Moffitt Cancer Center Tampa FL USA., Edwards J; Botnar Research Centre University of Oxford Oxford UK., Tantawy MN; Radiology and Vanderbilt Institute of Imaging Sciences Vanderbilt University School of Medicine Nashville TN USA., Hilliard T; Radiology and Vanderbilt Institute of Imaging Sciences Vanderbilt University School of Medicine Nashville TN USA., Wang S; Department of Medicine, Division of Rheumatology and Immunology Vanderbilt University School of Medicine Nashville TN USA., Peterson T; Radiology and Vanderbilt Institute of Imaging Sciences Vanderbilt University School of Medicine Nashville TN USA., Johnson RW; Vanderbilt Center for Bone Biology Vanderbilt University School of Medicine Nashville TN USA.; Vanderbilt-Ingram Cancer Center Vanderbilt University School of Medicine Nashville TN USA.; Department of Tumor Biology H. Lee Moffitt Cancer Center Tampa FL USA.; Division of Clinical Pharmacology Vanderbilt University School of Medicine Nashville TN USA., Sterling JA; Vanderbilt Center for Bone Biology Vanderbilt University School of Medicine Nashville TN USA.; Department of Veterans Affairs, Tennessee Valley Healthcare System (VISN 9) Vanderbilt University Nashville TN USA., Brantley-Sieders D; Vanderbilt-Ingram Cancer Center Vanderbilt University School of Medicine Nashville TN USA.; Department of Tumor Biology H. Lee Moffitt Cancer Center Tampa FL USA.; Radiology and Vanderbilt Institute of Imaging Sciences Vanderbilt University School of Medicine Nashville TN USA.; Department of Medicine, Division of Rheumatology and Immunology Vanderbilt University School of Medicine Nashville TN USA.

Publikováno v: JBMR plus [JBMR Plus] 2021 Mar 09; Vol. 5 (4), pp. e10465. Date of Electronic Publication: 2021 Mar 09 (Print Publication: 2021).

C1orf106 (INAVA) Is a SMAD3-Dependent TGF-β Target Gene That Promotes Clonogenicity and Correlates with Poor Prognosis in Breast Cancer.

Autor: Strathearn, Lauren S.^1,2 (AUTHOR) c.schoenherr@beatson.gla.ac.uk, Spender, Lindsay C.^1,3 (AUTHOR) l.spender@dundee.ac.uk, Schoenherr, Christina² (AUTHOR) s.mason@beatson.gla.ac.uk, Mason, Susan² (AUTHOR) karen.blyth@glasgow.ac.uk, Edwards, Ruaridh¹ (AUTHOR), Blyth, Karen² (AUTHOR), Inman, Gareth J.^1,2,4 (AUTHOR) gareth.inman@glasgow.ac.uk

Publikováno v: Cells (2073-4409). Sep2024, Vol. 13 Issue 18, p1530. 17p.

The EphA2 Receptor Regulates Invasiveness and Drug Sensitivity in Canine and Human Osteosarcoma Cells.

Autor: Harris, Evelyn D.¹ (AUTHOR) evelyn.harris@usask.ca, Sharpe, Jessica C.¹ (AUTHOR) jessica.sharpe@usask.ca, Strozen, Timothy¹ (AUTHOR) timothy.strozen@usask.ca, Abdi, Shabnam¹ (AUTHOR) shabnam.abdi@usask.ca, Kliewer, Maya¹ (AUTHOR) maya.kliewer@usask.ca, Sanchez, Malkon G.^1,2 (AUTHOR) mas925@mail.usask.ca, Hogan, Natacha S.³ (AUTHOR) natacha.hogan@usask.ca, MacDonald-Dickinson, Valerie¹ (AUTHOR) valerie.macdonald@usask.ca, Vizeacoumar, Franco J.⁴ (AUTHOR) franco.vizeacoumar@usask.ca, Toosi, Behzad M.¹ (AUTHOR) behzad.toosi@usask.ca

Publikováno v: Cells (2073-4409). Jul2024, Vol. 13 Issue 14, p1201. 17p.

The role of SIK3 in HER21 gastric cancer cells.

Autor: Scott, Kevin M. K.¹, Miyamoto, Yuko J.¹ ymiyamoto@elon.edu

Publikováno v: Bios. Jun2024, Vol. 95 Issue 2, p95-103. 9p.

Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.

Autor: Morrison Joly M; Department of Cancer Biology, Vanderbilt University School of Medicine, 2220 Pierce Avenue, Rm 749 Preston Research Building, Nashville, TN, 37232, USA., Williams MM; Department of Cancer Biology, Vanderbilt University School of Medicine, 2220 Pierce Avenue, Rm 749 Preston Research Building, Nashville, TN, 37232, USA., Hicks DJ; Department of Cancer Biology, Vanderbilt University School of Medicine, 2220 Pierce Avenue, Rm 749 Preston Research Building, Nashville, TN, 37232, USA., Jones B; Department of Cancer Biology, Vanderbilt University School of Medicine, 2220 Pierce Avenue, Rm 749 Preston Research Building, Nashville, TN, 37232, USA., Sanchez V; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA., Young CD; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA., Sarbassov DD; Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Muller WJ; Department of Biochemistry, McGill University, Montreal, Quebec, Canada., Brantley-Sieders D; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA., Cook RS; Department of Cancer Biology, Vanderbilt University School of Medicine, 2220 Pierce Avenue, Rm 749 Preston Research Building, Nashville, TN, 37232, USA. Rebecca.cook@vanderbilt.edu.

Publikováno v: Breast cancer research : BCR [Breast Cancer Res] 2017 Jun 30; Vol. 19 (1), pp. 74. Date of Electronic Publication: 2017 Jun 30.